SPRY
ARS Pharmaceuticals, Inc.$9.68+0.09 (+0.94%)Prev Close$9.59·MCap$850.0M·P/E—·Vol1.06M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
10
$17.72M
◆
Net Activity
Net Seller
$17.72M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at ARS Pharmaceuticals, Inc. (SPRY) has been exclusively selling, with 0 insider purchases totaling $0.00 and 10 insider sales totaling $17.72M. The most recent insider transaction was by Karas Eric (officer: Chief Commercial Officer), who sold $250.0K worth of shares on Jun 12, 2026. ARS Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $850.0M.
SPRY Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Karas Eric | officer: Chief Commercial Officer | Sell | 25,000 | $10.00 | $250.0K | 12,176-67% |
| Jun 12, 2026 | Fitzpatrick Alexander A | officer: Chief Legal Officer | Sell | 3,355 | $10.00 | $33.5K | 90,910 |
| Nov 13, 2025 | Dorsey Brian | Chief Operating Officer | Sell | 21,828 | $8.71 | $190.1K | 0 |
| Nov 12, 2025 | Chakma Justin | Chief Business Officer | Sell | 166,380 | $8.87 | $1.48M | 0 |
| Aug 21, 2025 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | 50,000 | $14.49 | $724.3K | 0 |
| Aug 21, 2025 | Scott Kathleen D. | Chief Financial Officer | Sell | 12,500 | $15.00 | $187.5K | 0 |
| Aug 19, 2025 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 50,000 | $14.08 | $703.8K | 0 |
| Jul 1, 2025 | Karas Eric | Chief Commercial Officer | Sell | 15,000 | $16.99 | $254.9K | 0 |
| Jun 27, 2025 | Flynn James E | 10% Owner | Sell | 740,149 | $18.46 | $13.66M0.7% OS | 0 |
| Jun 18, 2025 | Karas Eric | Chief Commercial Officer | Sell | 15,000 | $16.00 | $240.0K | 0 |
| May 20, 2025 | Fitzpatrick Alexander A | Chief Legal Officer | Sell | 102,969 | $14.10 | $1.45M | 0 |
| May 20, 2025 | SAUNDERS BRENT L | Director | Sell | 120,000 | $14.25 | $1.71M | 0 |
| May 20, 2025 | Scott Kathleen D. | Chief Financial Officer | Sell | 50,000 | $14.10 | $705.2K | 0 |
| Apr 7, 2025 | Shawver Laura | Director | Sell | 50,002 | $12.30 | $615.1K | 0 |
| Mar 20, 2025 | Karas Eric | Chief Commercial Officer | Sell | 10,000 | $14.00 | $140.0K | 0 |
| Mar 5, 2025 | Shawver Laura | Director | Sell | 50,000 | $11.21 | $560.4K | 0 |
| Feb 4, 2025 | Shawver Laura | Sell | 50,000 | $12.31 | $615.6K | 210,346 | |
| Jan 7, 2025 | Shawver Laura | Sell | 50,000 | $11.10 | $555.1K | 210,346 | |
| Dec 19, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $11.67 | $1.17M | 1,297,447 |
| Dec 13, 2024 | Chakma Justin | Chief Business Officer | Sell | 144,605 | $12.23 | $1.77M | 136,380-51% |
| Dec 13, 2024 | Dorsey Brian | Chief Operating Officer | Sell | 40,000 | $12.35 | $493.9K | 6,024-87% |
| Dec 12, 2024 | Chakma Justin | Chief Business Officer | Sell | 50,000 | $13.15 | $657.6K | 136,380-27% |
| Dec 11, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $13.16 | $1.32M | 1,246,494 |
| Dec 6, 2024 | Chakma Justin | Chief Business Officer | Sell | 144,640 | $14.11 | $2.04M | 136,380-51% |
| Dec 4, 2024 | Chakma Justin | Chief Business Officer | Sell | 90,000 | $13.43 | $1.21M | 136,380-40% |
| Dec 4, 2024 | Karas Eric | Chief Commercial Officer | Sell | 10,000 | $14.04 | $140.4K | 5,693-64% |
| Dec 4, 2024 | Shawver Laura | Sell | 200,000 | $13.44 | $2.69M | 211,247-49% | |
| Nov 27, 2024 | Chakma Justin | Chief Business Officer | Sell | 100,000 | $14.12 | $1.41M | 203,566-33% |
| Nov 21, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | 100,000 | $13.95 | $1.39M | 1,347,447 |
| Nov 14, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $16.85 | $1.68M | 1,301,449 |
| Nov 13, 2024 | Flynn James E | 10% Owner | Sell | 299,042 | $17.98 | $5.38M | 5,498,368 |
| Oct 17, 2024 | Scott Kathleen D. | Chief Financial Officer | Sell | 12,500 | $16.00 | $200.0K | 4,949-72% |
| Oct 17, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $14.88 | $1.49M | 1,398,897 |
| Oct 10, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $13.83 | $1.38M | 1,348,499 |
| Sep 19, 2024 | Karas Eric | Chief Commercial Officer | Sell | 10,000 | $14.00 | $140.0K | 5,693-64% |
| Sep 19, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $12.93 | $1.29M | 1,447,447 |
| Sep 12, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $11.50 | $1.15M | 1,448,499 |
| Aug 28, 2024 | Thompson Peter A. | Director | Sell | 83,695 | $13.00 | $1.09M | 0Exit |
| Aug 23, 2024 | Thompson Peter A. | Director | Sell | 868,682 | $13.24 | $11.50M0.9% OS | 557,977-61% |
| Aug 21, 2024 | Dorsey Brian | Chief Operating Officer | Sell | 50,000 | $15.00 | $750.0K | 6,024-89% |
| Aug 21, 2024 | Karas Eric | Chief Commercial Officer | Sell | 10,000 | $14.00 | $140.0K | 5,693-64% |
| Aug 21, 2024 | Scott Kathleen D. | Chief Financial Officer | Sell | 12,500 | $16.00 | $200.0K | 13,199-49% |
| Aug 21, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $15.03 | $1.50M | 1,512,283 |
| Aug 15, 2024 | Dorsey Brian | Chief Operating Officer | Sell | 30,000 | $13.00 | $390.0K | 6,024-83% |
| Aug 15, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $12.48 | $1.25M | 1,583,862 |
| Jul 18, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | 100,000 | $11.40 | $1.14M | 1,598,499 |
| Jul 11, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $9.62 | $961.7K | 1,648,499 |
| Jun 13, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | 100,000 | $9.14 | $913.9K | 1,746,527 |
| May 16, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $9.05 | $905.4K | 1,795,615 |
| May 9, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $9.34 | $934.4K | 1,798,499 |
Showing 1–50 of 71
1 / 2
SPRY Insider Buying Activity
The following table shows recent insider purchases of ARS Pharmaceuticals, Inc. (SPRY) stock reported via SEC Form 4 filings.
No insider buying activity found for SPRY in the last 12 months.
SPRY Insider Selling Activity
The following table shows recent insider sales of ARS Pharmaceuticals, Inc. (SPRY) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Karas Eric | officer: Chief Commercial Officer | Sell | 25,000 | $10.00 | $250.0K | 12,176-67% |
| Jun 12, 2026 | Fitzpatrick Alexander A | officer: Chief Legal Officer | Sell | 3,355 | $10.00 | $33.5K | 90,910 |
| Nov 13, 2025 | Dorsey Brian | Chief Operating Officer | Sell | 21,828 | $8.71 | $190.1K | 0 |
| Nov 12, 2025 | Chakma Justin | Chief Business Officer | Sell | 166,380 | $8.87 | $1.48M | 0 |
| Aug 21, 2025 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | 50,000 | $14.49 | $724.3K | 0 |
| Aug 21, 2025 | Scott Kathleen D. | Chief Financial Officer | Sell | 12,500 | $15.00 | $187.5K | 0 |
| Aug 19, 2025 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 50,000 | $14.08 | $703.8K | 0 |
| Jul 1, 2025 | Karas Eric | Chief Commercial Officer | Sell | 15,000 | $16.99 | $254.9K | 0 |
| Jun 27, 2025 | Flynn James E | 10% Owner | Sell | 740,149 | $18.46 | $13.66M0.7% OS | 0 |
| Jun 18, 2025 | Karas Eric | Chief Commercial Officer | Sell | 15,000 | $16.00 | $240.0K | 0 |
| May 20, 2025 | Fitzpatrick Alexander A | Chief Legal Officer | Sell | 102,969 | $14.10 | $1.45M | 0 |
| May 20, 2025 | SAUNDERS BRENT L | Director | Sell | 120,000 | $14.25 | $1.71M | 0 |
| May 20, 2025 | Scott Kathleen D. | Chief Financial Officer | Sell | 50,000 | $14.10 | $705.2K | 0 |
| Apr 7, 2025 | Shawver Laura | Director | Sell | 50,002 | $12.30 | $615.1K | 0 |
| Mar 20, 2025 | Karas Eric | Chief Commercial Officer | Sell | 10,000 | $14.00 | $140.0K | 0 |
| Mar 5, 2025 | Shawver Laura | Director | Sell | 50,000 | $11.21 | $560.4K | 0 |
| Feb 4, 2025 | Shawver Laura | Sell | 50,000 | $12.31 | $615.6K | 210,346 | |
| Jan 7, 2025 | Shawver Laura | Sell | 50,000 | $11.10 | $555.1K | 210,346 | |
| Dec 19, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $11.67 | $1.17M | 1,297,447 |
| Dec 13, 2024 | Chakma Justin | Chief Business Officer | Sell | 144,605 | $12.23 | $1.77M | 136,380-51% |
| Dec 13, 2024 | Dorsey Brian | Chief Operating Officer | Sell | 40,000 | $12.35 | $493.9K | 6,024-87% |
| Dec 12, 2024 | Chakma Justin | Chief Business Officer | Sell | 50,000 | $13.15 | $657.6K | 136,380-27% |
| Dec 11, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $13.16 | $1.32M | 1,246,494 |
| Dec 6, 2024 | Chakma Justin | Chief Business Officer | Sell | 144,640 | $14.11 | $2.04M | 136,380-51% |
| Dec 4, 2024 | Chakma Justin | Chief Business Officer | Sell | 90,000 | $13.43 | $1.21M | 136,380-40% |
| Dec 4, 2024 | Karas Eric | Chief Commercial Officer | Sell | 10,000 | $14.04 | $140.4K | 5,693-64% |
| Dec 4, 2024 | Shawver Laura | Sell | 200,000 | $13.44 | $2.69M | 211,247-49% | |
| Nov 27, 2024 | Chakma Justin | Chief Business Officer | Sell | 100,000 | $14.12 | $1.41M | 203,566-33% |
| Nov 21, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | 100,000 | $13.95 | $1.39M | 1,347,447 |
| Nov 14, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $16.85 | $1.68M | 1,301,449 |
| Nov 13, 2024 | Flynn James E | 10% Owner | Sell | 299,042 | $17.98 | $5.38M | 5,498,368 |
| Oct 17, 2024 | Scott Kathleen D. | Chief Financial Officer | Sell | 12,500 | $16.00 | $200.0K | 4,949-72% |
| Oct 17, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $14.88 | $1.49M | 1,398,897 |
| Oct 10, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $13.83 | $1.38M | 1,348,499 |
| Sep 19, 2024 | Karas Eric | Chief Commercial Officer | Sell | 10,000 | $14.00 | $140.0K | 5,693-64% |
| Sep 19, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $12.93 | $1.29M | 1,447,447 |
| Sep 12, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $11.50 | $1.15M | 1,448,499 |
| Aug 28, 2024 | Thompson Peter A. | Director | Sell | 83,695 | $13.00 | $1.09M | 0Exit |
| Aug 23, 2024 | Thompson Peter A. | Director | Sell | 868,682 | $13.24 | $11.50M0.9% OS | 557,977-61% |
| Aug 21, 2024 | Dorsey Brian | Chief Operating Officer | Sell | 50,000 | $15.00 | $750.0K | 6,024-89% |
| Aug 21, 2024 | Karas Eric | Chief Commercial Officer | Sell | 10,000 | $14.00 | $140.0K | 5,693-64% |
| Aug 21, 2024 | Scott Kathleen D. | Chief Financial Officer | Sell | 12,500 | $16.00 | $200.0K | 13,199-49% |
| Aug 21, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $15.03 | $1.50M | 1,512,283 |
| Aug 15, 2024 | Dorsey Brian | Chief Operating Officer | Sell | 30,000 | $13.00 | $390.0K | 6,024-83% |
| Aug 15, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $12.48 | $1.25M | 1,583,862 |
| Jul 18, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | 100,000 | $11.40 | $1.14M | 1,598,499 |
| Jul 11, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $9.62 | $961.7K | 1,648,499 |
| Jun 13, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | 100,000 | $9.14 | $913.9K | 1,746,527 |
| May 16, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $9.05 | $905.4K | 1,795,615 |
| May 9, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 100,000 | $9.34 | $934.4K | 1,798,499 |
SPRY Insiders
Fitzpatrick Alexander A
officer: Chief Legal Officer
Bought $320.0KSold $1.49M
3 tradesLast: Jun 12, 2026
Similar Stocks to SPRY
VRTX
Vertex Pharmaceuticals Incorporated
$445.21+0.04%
$113.41B
REGN
Regeneron Pharmaceuticals, Inc.
$614.20+0.45%
$65.47B
ALNY
Alnylam Pharmaceuticals, Inc.
$283.35-2.09%
$40.46B
RVMD
Revolution Medicines, Inc.
$153.65+2.96%
$31.73B
UTHR
United Therapeutics Corporation
$542.43-0.54%
$23.12B
INSM
Insmed Incorporated
$98.28+1.64%
$20.41B
INCY
Incyte Corporation
$108.85+0.95%
$20.11B
MRNA
Moderna, Inc.
$50.18+1.06%
$18.89B